CLINICAL_TRIALS
trial_result
· 2021-12-06
Clinical Trial Update: Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate [Phase 2]
Summary
Phase IIb dose-ranging trial of BMS-945429 in methotrexate-not-responsive rheumatoid arthritis completed; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CSL Behring | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2021-12-06